Shengqiang Fu
Papers
2
Total Citations
59
H-Index
2
About
Dr. Shengqiang Fu is a pioneering urologic surgeon whose research focuses on advancing minimally invasive surgical techniques for complex urological cancers. His major contributions center on comparative effectiveness studies of robotic surgical systems, particularly evaluating the da Vinci Xi versus da Vinci Si platforms for radical prostatectomy. His landmark 2021 study, cited 30 times, provided crucial evidence on perioperative outcomes and cost-effectiveness between these robotic systems, helping guide surgical decision-making in prostate cancer treatment. Dr. Fu has also made significant strides in adrenal surgery, with his 2020 investigation of robot-assisted retroperitoneal laparoscopic adrenalectomy for large pheochromocytomas (tumors ≥6 cm) earning 29 citations. This work demonstrated the feasibility and safety of robotic approaches for challenging adrenal tumors, expanding surgical options for patients with complex endocrine conditions. His research has directly influenced operative protocols and patient selection criteria in robotic urologic oncology. Through meticulous retrospective analyses and comparative methodology, Dr. Fu has established himself as a key voice in evidence-based robotic surgery, bridging the gap between technological innovation and clinical application. His work continues to shape best practices in minimally invasive urologic oncology.
Research Focus
Key Achievements
Top Papers
- 1
- 2